Time from venipuncture to cell isolation: Impact on granulocyte-reactive antibody testing.

Granulocyte immunology Granulocyte-reactive antibody Human neutrophil antigens Laboratory medicine Neutrophil stability Transfusion medicine

Journal

Clinical biochemistry
ISSN: 1873-2933
Titre abrégé: Clin Biochem
Pays: United States
ID NLM: 0133660

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 03 08 2018
revised: 29 10 2018
accepted: 30 10 2018
pubmed: 18 11 2018
medline: 12 1 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Classical neutrophil-reactive antibody testing depends on the quick isolation of neutrophils from freshly taken whole blood. To allow a better logistic preparation before testing, the influence of time interval between venipuncture and cell isolation has been evaluated in this study. Neutrophils and whole leukocytes were isolated from EDTA whole blood immediately (T0) as well as 4, 8 and 24 h after blood donation (T4, T8 and T24). These cells were tested against reference sera containing antibodies against HNA-1b, -2, -3a and HLA class I using granulocyte aggregation test (GAT), microscopic granulocyte immunofluorescence test (GIFT) and flow-cytometric white blood cell immunofluorescence test (Flow-GIFT/WIFT). GAT was the most error-prone test displaying overall weaker aggregation strengths already at T4 (overall accuracy OA = 0.72, κ = 0.58). GIFT results showed good agreement at T4 (OA = 0.86, κ = 0.79) and remained stable until T8, while test results were slightly impaired at T24 (OA = 0.71, κ = 0.55). Flow-GIFT/WIFT was identified as the most robust screening method, remaining stable even at T24. Calculated ratios (sample/negative control) decreased non-significantly and remained highly above the cut-off in all samples. Acceptable time limits for cell isolation are different for each screening method investigated. For GAT, cell isolation should be performed within 4 h, while GIFT tolerates a neutrophil isolation delay of 8 h. Flow-GIFT/WIFT isolation can be performed even after 24 h without impairment of the results. Using the latter test as a stand-alone pre-screening test, whole blood can be used from donors who are not directly accessible.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Classical neutrophil-reactive antibody testing depends on the quick isolation of neutrophils from freshly taken whole blood. To allow a better logistic preparation before testing, the influence of time interval between venipuncture and cell isolation has been evaluated in this study.
MATERIALS AND METHODS METHODS
Neutrophils and whole leukocytes were isolated from EDTA whole blood immediately (T0) as well as 4, 8 and 24 h after blood donation (T4, T8 and T24). These cells were tested against reference sera containing antibodies against HNA-1b, -2, -3a and HLA class I using granulocyte aggregation test (GAT), microscopic granulocyte immunofluorescence test (GIFT) and flow-cytometric white blood cell immunofluorescence test (Flow-GIFT/WIFT).
RESULTS RESULTS
GAT was the most error-prone test displaying overall weaker aggregation strengths already at T4 (overall accuracy OA = 0.72, κ = 0.58). GIFT results showed good agreement at T4 (OA = 0.86, κ = 0.79) and remained stable until T8, while test results were slightly impaired at T24 (OA = 0.71, κ = 0.55). Flow-GIFT/WIFT was identified as the most robust screening method, remaining stable even at T24. Calculated ratios (sample/negative control) decreased non-significantly and remained highly above the cut-off in all samples.
CONCLUSION CONCLUSIONS
Acceptable time limits for cell isolation are different for each screening method investigated. For GAT, cell isolation should be performed within 4 h, while GIFT tolerates a neutrophil isolation delay of 8 h. Flow-GIFT/WIFT isolation can be performed even after 24 h without impairment of the results. Using the latter test as a stand-alone pre-screening test, whole blood can be used from donors who are not directly accessible.

Identifiants

pubmed: 30447182
pii: S0009-9120(18)30828-2
doi: 10.1016/j.clinbiochem.2018.10.017
pii:
doi:

Substances chimiques

Antibodies, Antineutrophil Cytoplasmic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-78

Informations de copyright

Copyright © 2018 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Auteurs

Marlies Schönbacher (M)

Medical University of Vienna, Department of Blood Group Serology and Transfusion Medicine, Austria.

Wolfgang R Mayr (WR)

Medical University of Vienna, Department of Blood Group Serology and Transfusion Medicine, Austria.

Torsten J Schulze (TJ)

German Red Cross Blood Service NSTOB, Institute Springe, Springe, Germany.

Gerda Leitner (G)

Medical University of Vienna, Department of Blood Group Serology and Transfusion Medicine, Austria.

Claas Schmidt (C)

Heinrich Heine University Düsseldorf, Institute of Clinical Chemistry and Laboratory Diagnostics, Germany.

Günther Hofbauer (G)

Medical University of Vienna, Core Facility of Flow Cytometry, Austria.

Alexander Tolios (A)

Medical University of Vienna, Department of Blood Group Serology and Transfusion Medicine, Austria; Heinrich Heine University Düsseldorf, Institute of Clinical Chemistry and Laboratory Diagnostics, Germany. Electronic address: alexander.tolios@meduniwien.ac.at.

Günther F Körmöczi (GF)

Medical University of Vienna, Department of Blood Group Serology and Transfusion Medicine, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH